Implementing Spiritual Care in Inpatient Palliative Care
Launched by UNIVERSITY HOSPITAL MUENSTER · Jan 4, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Implementing Spiritual Care in Inpatient Palliative Care," is focused on understanding and addressing the spiritual needs of patients receiving palliative care—those who are dealing with serious conditions like cancer, heart failure, chronic obstructive pulmonary disease, and lateral sclerosis. The researchers aim to use a tool called the Spiritual Needs Questionnaire to identify these needs and provide specialized spiritual care to improve patients’ well-being during their treatment. By comparing information collected from patients, the study hopes to find out how beneficial this approach is and whether it can be effectively offered by spiritual care providers.
To participate in this trial, individuals must be adults aged 65 and older with serious health conditions and a life expectancy of at least two weeks. They should be receiving care from palliative caregivers and have the ability to understand and complete the questionnaire in German. Patients with severe cognitive impairments or those unable to provide consent cannot take part in the study. If eligible, participants can expect to share their spiritual needs and receive support tailored to help them during their illness. This trial is currently recruiting participants at Muenster University Hospital, and the findings could help improve spiritual care for patients facing serious health challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * All individual indication for general and specialised Palliative Care in clinical setting/routine (e.g.):
- • Progressive, malign tumours
- • Progressive, chronic obstructive pulmonary disease
- • Patients with progressive disease and limited life expectancy (\< ca. 12 months)
- • Patients attended by Palliative Caregivers in counselling services or on palliative ward
- • Life expectancy \> 2 weeks
- • Sufficient comprehension of German language and writing that allows an autonomous or supported completion of the questionnaire.
- • Existence of an independently signed written consent.
- Exclusion Criteria:
- • Severe cognitive impairment
- • capacity for consent lacking or impaired
- • impaired comprehension of German language and writing that would not allow an autonomous or supported completion of the questionnaire.
About University Hospital Muenster
University Hospital Münster is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous investigations aimed at improving patient outcomes and developing new therapeutic strategies. With a strong focus on collaboration and ethical research practices, University Hospital Münster plays a pivotal role in translating scientific discoveries into practical applications, fostering a culture of inquiry that benefits both the medical community and the patients it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Muenster, North Rhine Westphalia, Germany
Patients applied
Trial Officials
Philipp Lenz, Prof. Dr. med.
Principal Investigator
University Hospital Muenster
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported